TapImmune to Provide First Quarter 2017 Business Update Conference Call and Webcast

First Quarter 2017 Business Update, May 31, 2017, 4:30pm ET

[/vc_column_text][vc_empty_space height=”8px”][vc_column_text]JACKSONVILLE, FLORIDA – May 18, 2017 – TapImmune, Inc. (NASDAQ: TPIV), a clinical-stage immuno-oncology company specializing in the development of immunotherapies targeting women’s cancers, today announced that the Company will host a conference call and live audio webcast on Wednesday, May 31, 2017, at 4:30 p.m. ET, to provide a corporate and clinical update for the first quarter 2017.

Reserve Your Seat: Register Today

The event will be webcast live via the Internet on:

May 31, 2017

4:30 PM ET

Click here to register today, or visit https://www.markertherapeutics.com/register/.

Day-of Call-in Information:

To access the live conference call, dial:

  • (877) 870-4263 (U.S.)
  • (412) 317-0790 (International)

To access the live audio webcast, visit the Events section of the TapImmune website https://www.markertherapeutics.com/events/. The webcast will also be archived for 90 days beginning at approximately 6:30 p.m. ET, on May 31, 2017.[/vc_column_text][vc_empty_space height=”25px”][vc_column_text][pr-disclaimer]